NASDAQ:ACRS

Aclaris Therapeutics, Inc Earning Date

USA |NASDAQ |USD

ACRS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 2, 2021 Sep 2021 $-0.28 $-0.34 $-0.25
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 2, 2021 Sep 2021 $1.77M $1.82M $1.45M

Aclaris Therapeutics, Inc's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 2021.

ACRS Earnings Date & History Chart

ACRS Earnings & Revenue Forecast

ACRS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.37 $-0.69 $-0.21
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-1.54 $-1.95 $-1.27
Dec 2022 6 $-1.46 $-2.00 $-1.13

ACRS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.37 $-0.37 $-0.33
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.54 $-1.54 $-1.34
Dec 2022 0 / 0 $-1.46 $-1.46 $-1.32

ACRS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $1.78M $1.40M $2.10M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $7.17M $6.50M $7.70M
Dec 2022 6 $7.60M $6.50M $8.90M

ACRS Earnings Date & Revenue History

ACRS Earnings History

|
Show More
Show More

ACRS Revenue History

|
Show More
Show More

Aclaris Therapeutics, Inc Next Earnings Date & Report

ACRS Next Earnings Date & Report Preview: Sep 2021 (FQ)

ACRS's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Aclaris Therapeutics, Inc's next quarterly earnings is $-0.28, with a low EPS estimation of $-0.35, and a high estimation of $-0.20.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.28, the last 2 month trend is $-0.28, and the 3 month trend is $-0.29.

Based on 6 analysts, the average revenue estimation is $1.77M, with a low revenue estimation of $1.50M, and a high estimation of $2.00M.

Aclaris Therapeutics, Inc Previous Earnings Dates & Reports

ACRS Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Aclaris Therapeutics, Inc's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

ACRS's earnings per share (EPS) was $-0.34, missing the consensus analysts forecast of $-0.28 by -21.43%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -40.35%, and lower than the same period a year before (Jun 2020) by 21.43%.

Revenues were $1.82M, better than the forecast of $1.75M by 4.23%, up by 2.64% from the previous quarter , and down by -10.85% from the same period last year.

The company reported a net income of $-18.16M.

Free cash flow for the quarter was $-12.27M , compared to $-12.23M last quarter and $-10.84M a year before.

ACRS ended the quarter with $11.38M in total debt, an increase of 0.54% compared to the previous quarter, and an increase of 1.74% compared to the same quarter a year before.

ACRS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aclaris Therapeutics, Inc's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

ACRS's earnings per share (EPS) was $-1.20, missing the consensus analysts forecast of $-1.16 by 3.45% , and higher than the previous year's EPS (Dec 2019) by -69.31%.

Revenues were $6.48M, better than the forecast of $6.29M by 3.05%, and up by 53.35% from previous year's revenue.

The company reported a net income of $-51.02M.

Aclaris Therapeutics, Inc reported a free cash flow of $-39.09M for its fiscal year, compared to $-98.06M a year ago.

The company ended the fiscal year with $11.26M in total debt, an increase of 1667.03% compared to the previous year.